Compliance With Post-Approval Commitments Goes Public On CDRH Web Site

A Web site that will publicly display the status of FDA-required post-approval medical device studies will be operational within weeks, according to Steven Chasin, deputy director of the postmarket surveillance division at CDRH's Office of Surveillance & Biometrics